TrialMuscle & nerve2021

Safety, tolerability, and pharmacokinetics of casimersen in patients with Duchenne muscular dystrophy amenable to exon 45 skipping: A randomized, double-blind, placebo-controlled, dose-titration trial.

Kathryn R Wagner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.